Like most functional medicine practices, a large part of our practice involves treating chronic conditions because conventional medicine, for the most part, is concerned solely with symptom relief
In Phase II trials: Efinopegdutide (Merck/Johnson & Johnson/Hanmi Harma), VK2735 (Viking Therapeutics), BGM0504 (BrightGene), Pemvidutide (Altimmune/Spitfire Pharma), AMG133 (Amgen), Dapiglutide (Zealand Pharma), etc
Rotate injection sites to minimize tissue irritation
The GH axis is a legitimate target for muscle preservation
That well-characterized population, along with other women presenting for breast cancer screening, would be ideally suited to study the preventive effects of the GLP1 drugs in a prospective clinical trial.